March 10, 2014
Researchers at the University of Virginia are now taking part in a nationwide search for treatments for several brain and neurological conditions, and they're starting with multiple sclerosis.
It's all part of the NeuroNEXT program, which is funded by the National Institute of Health. Nearly thirty hospitals from around the country are taking part in the program.
Each hospital can sign up for drug trials to help test new treatments quickly and efficiently. Right now, UVa is enrolling patients for a study of a new drug that is designed to help patients with progressive M-S.
Researchers say this program is a way to make sure more drugs get tested.
"Traditionally this is done through pharmaceutical companies, which leaves drugs that are potentially not profitable neglected,” said Assistant Professor of Neurology Myla Goldman, M.D. “So this is a network that will ensure that any drug that may have the potential for benefit will be tested."
The university’s MS study will follow patients for two years, testing the safety of the drug first, and also measuring any benefits it could have.